Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]

16505 reported adverse events

Drugs of this class: LIFITEGRAST

These side effects are most commonly reported by patients taking drugs of the Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] class:

# Side effect Count
0 EYE IRRITATION 2780
1 VISION BLURRED 2679
2 DRUG INEFFECTIVE 1629
3 EYE PAIN 1460
4 INSTILLATION SITE PAIN 1283
5 DRY EYE 1187
6 DYSGEUSIA 1118
7 INSTILLATION SITE REACTION 1019
8 OCULAR HYPERAEMIA 707
9 LACRIMATION INCREASED 636
See all common reactions for Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]

Drugs of the Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INSTILLATION SITE REACTION 1019 0.9349
1 INSTILLATION SITE LACRIMATION 179 0.7397
2 INSTILLATION SITE INFLAMMATION 33 0.5893
3 INSTILLATION SITE BURN 24 0.5581
4 INSTILLATION SITE PAIN 1283 0.5173
5 INSTILLATION SITE DISCOMFORT 68 0.5075
6 INSTILLATION SITE PRURITUS 189 0.5013
7 INSTILLATION SITE DISCHARGE 118 0.4487
8 INSTILLATION SITE SWELLING 76 0.4343
9 INSTILLATION SITE ERYTHEMA 210 0.3977
See all enriched reactions for Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]